Clearmind Medicine Shares On The Move With Cash Question Looming
Clearmind Medicine Inc. traded up midday Thursday on Nasdaq. Investors looked at a new financing filing and waited for an update on the company’s lead alcohol-use-disorder study. The micro-cap biotech’s cash levels stayed in focus. The stock gained 1.7% to $2.96, moving between $2.80 and $3.00 so far, with volume at roughly 52,846 shares on the latest feed. The move isn’t big, but for a smaller name, even some light action will shift the price.